AbCellera is a biotechnology firm dedicated to advancing antibody-based therapeutics. By integrating technology, data science, and interdisciplinary expertise, AbCellera accelerates the discovery and development of novel antibody medicines. The company collaborates with leading pharmaceutical partners to address complex health challenges across various therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera's commitment to innovation and patient-centric solutions positions it at the forefront of the biotechnology industry.